clinical discussion regarding choice of therapy for polycythemia vera (pv)
Published 9 years ago • 86 plays • Length 20:09Download video MP4
Download video MP3
Similar videos
-
17:54
current therapy options and clinical outcomes analysis in patients with pv
-
19:03
assessment of novel treatment options for patients with pv
-
8:03
goals of therapy in polycythemia vera
-
19:41
recent advances in the diagnosis, prognosis and survival predictions of patients with pv
-
18:19
biomarker and surrogate targets for successful therapy in polycythemia vera (pv)
-
19:49
what is the current standard of care in treating polycythemia vera (pv)?
-
12:31
latest in polycythemia vera (pv) and promising treatments | dr. serge vertovsek, md anderson
-
6:07
available treatment options for patients with pv
-
17:02
indication for cytoreductive therapy in et and pv: do we have it right?
-
52:50
use of cytoreductive therapy in patients with low risk polycythemia vera
-
7:08
an overview of et, pv and mf treatment options
-
4:06
initiating treatment for polycythemia vera
-
5:43
moving beyond hydroxyurea for polycythemia vera
-
1:30
the patient perspective of polycythemia vera and second-line treatment options
-
2:14
the role of bmt & clinical trials in patients with pv with multiple treatment-limiting toxicities
-
1:52
cytoreductive therapy for patients with pv
-
5:27
case 2: the diagnosis of polycythemia vera
-
4:52
treating pv with jak inhibition now and in the future
-
4:43
the role of ruxolitinib in treating polycythemia vera